Cited by CrossRef (40)
- Hee Yeon Seo, Tae Hwa Ko, Shin Young Hyun, Hyebin Song, Seung Taek Lim, Kwang Yong Shim, Jong In Lee, Jee Hyun Kong. Tyrosine Kinase Inhibitor Dosing Patterns in Elderly Patients With Chronic Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 2019;19:735
- Suellen Valadares Moura Feliciano, Marceli de Oliveira Santos, Maria S. Pombo-de-Oliveira, Josefa Ângela Pontes de Aquino, Terezinha Almeida de Aquino, Miren Maite Uribe Arregi, Berenice Navarro Antoniazzif, Allini Mafra da Costa, Lucrecia Aline Cabral Formigosa, Cyntia Asturian Laporte, Carlos Anselmo Lima, Nayara Cabral Machado, José Carlo de Oliveira, Larissa Dell’Antonio Pereira, Adriana de Souza, Cristina Maria Almeida dos Santos, Paulo Cesar Fernandes de Souza, Donaldo Botelho Venezian. Incidence and mortality of myeloid malignancies in children, adolescents and Young adults in Brazil: A population-based study. Cancer Epidemiology 2019;62:101583
- Jae-Sook Ahn. Molecular Risk Stratification using Next-generation Sequencing in Acute Myeloid Leukemia. Korean J Med 2021;96:493
- Htet Lin Htun, Weixiang Lian, Joshua Wong, En Jie Tan, Ling Li Foo, Kiat Hoe Ong, Wei-Yen Lim. Classic myeloproliferative neoplasms in Singapore: A population-based study on incidence, trends, and survival from 1968 to 2017. Cancer Epidemiology 2022;79:102175
- Ye-eun Jeon, Jea Chul Ha, Seonggyu Kim, Mi Hwa Heo, Young Rok Do, Insung Chung. Acute myeloid leukemia in a farmer with long term exposure to pesticides in Korea. 2022;3:e0189
- Richard F. Schlenk, Sonia Jaramillo, Carsten Müller-Tidow. What's new in consolidation therapy in AML?. Seminars in Hematology 2019;56:96
- Jae-Sook Ahn, Hyeoung-Joon Kim. FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs. Blood Res 2022;57:S32
- Yoojoo Lim, Jeong-Ok Lee, Soo-Mee Bang. Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea. J Korean Med Sci 2016;31:1579
- Jae Joon Han. Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia. Blood Res 2023;58:S58
- Ka-Won Kang, Hyoseon Kim, Woojune Hur, Jik-han Jung, Su Jin Jeong, Hyunku Shin, Dongkwon Seo, Hyesun Jeong, ByeongHyeon Choi, Sunghoi Hong, Hyun Koo Kim, Yeonho Choi, Ji-ho Park, Kil Yeon Lee, Kwang Pyo Kim, Yong Park. A Proteomic Approach to Understand the Clinical Significance of Acute Myeloid Leukemia–Derived Extracellular Vesicles Reflecting Essential Characteristics of Leukemia. Molecular & Cellular Proteomics 2021;20:100017
- Yan Jiang, Jean-Richard Eveillard, Marie-Anne Couturier, Benoit Soubise, Jian-Min Chen, Sujun Gao, Audrey Basinko, Frédéric Morel, Nathalie Douet-Guilbert, Marie-Bérengère Troadec. Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations. Cancers 2021;13:481
- Hwanjoo Ko, Eungyeong Jang, Youngchul Kim. Rhus Verniciflua Stokes Extract Suppresses Expression of Metalloproteinases, iNOS and COX-2 in THP-1 Cells Via Inhibiting NF-κB and MAPK Phosphorylation. J Korean Med 2020;41:12
- Won-Ju Park, Joo-heon Park, Seunghyeon Cho, Myung Geun Shin. Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999-2018. Blood Res 2021;56:301
- Huan Li, Fang Hu, Robert Peter Gale, Mikkael A. Sekeres, Yang Liang. Myelodysplastic syndromes. Nat Rev Dis Primers 2022;8
- Soo-Mee Bang, Ka-Won Kang, Ik-Chan Song, Cynthia Llamas, Yinghui Duan, Ji-Young Jeong, Je-Hwan Lee. Real-World Treatment Patterns and Clinical Outcomes in Korean Patients With AML Ineligible for First-Line Intensive Chemotherapy: A Subanalysis of the CURRENT Study, a Non-Interventional, Retrospective Chart Review. J Korean Med Sci 2023;38
- Sonia Jaramillo, Richard F. Schlenk. Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question. haematol 2023;108:342
- Silvia Park, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung-Hwan Shin, Jae-Ho Yoon, Sung-Eun Lee, Byung Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong Wook Lee, Hee-Je Kim. Comparison of Myeloablative (CyTBI, BuCy) versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Pretransplant Low WT1 Expression. Biology of Blood and Marrow Transplantation 2020;26:2018
- Xiaofei Zhou, Sharon Friedlander, Erik Kupperman, Farhad Sedarati, Shingo Kuroda, Zhaowei Hua, Ying Yuan, Yuka Yamamoto, Douglas V. Faller, Kazue Haikawa, Katsuhiko Nakai, Sharon Bowen, Yi Dai, Karthik Venkatakrishnan. Asia‐inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial. Clinical Translational Sci 2021;14:1069
- Jongheon Jung, Eunyoung Lee, Hyoeun Shim, Ju-Hyun Park, Hyeon-Seok Eom, Hyewon Lee. Prediction of clinical outcomes through assessment of sarcopenia and adipopenia using computed tomography in adult patients with acute myeloid leukemia. Int J Hematol 2021;114:44
- Hyoung Soo Choi, Junshik Hong, Sang Mee Hwang, Ju Hyun Lee, Youngeun Ma, Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang. Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms. Ann Hematol 2021;100:2567
- Seonghee Joo, Eungyeong Jang, Youngchul Kim. Effect of Orostachys japonicus on Apoptosis and Autophagy in Human monocytic leukemia Cell line THP-1 via Inhibition of NF-κB and Phosphorylation of p38 MAPK. J Korean Med 2019;40:35
- Tine Bichel Lauritsen, Jan Maxwell Nørgaard, Susanne Oksbjerg Dalton, Kirsten Grønbæk, Tarec Christoffer El-Galaly, Lene Sofie Granfeldt Østgård. 10-year nationwide trends in incidence, treatment patterns, and mortality of patients with myelodysplastic syndromes in Denmark. Leukemia Research 2023;128:107056
- Jieun Uhm, Kyoung Ha Kim, Hyewon Lee, Hawk Kim, Slader Cassandra, Inkyung Joo, Chul Won Jung. Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey. Blood Res 2021;56:31
- Hyerim Ha, Yujin Jeong, Joo Han Lim, Young Ju Suh. Treatment Pattern, Financial Burden, and Outcomes in Elderly Patients with Acute Myeloid Leukemia in Korea: A Nationwide Cohort Study. IJERPH 2022;19:2317
- Amer M. Zeidan, Rory M. Shallis, Rong Wang, Amy Davidoff, Xiaomei Ma. Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it. Blood Reviews 2019;34:1
- Hwa Jung Yook, Joon Ho Son, Yeong Ho Kim, Ju Hee Han, Ji Hyun Lee, Young Min Park, Nack-Gyun Chung, Hee Je Kim, Chul Hwan Bang. Leukaemia Cutis: Clinical Features and Outcomes of 56 Patients. Acta Derm Venereol 2022;102:adv00647
- Hyun-Young Kim, Keon Hee Yoo, Chul Won Jung, Hee-Jin Kim, Sun-Hee Kim. Genetic Characteristics of Patients with Young-Onset Myelodysplastic Neoplasms. JCM 2023;12:7651
- S.N. ABDULLAEVA. SOME ASPECTS OF EPIDEMIOLOGY, PATHOGENESIS, DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA. AB 2021;23:395
- Ka-Won Kang, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Seok Jin Kim, Chul Won Choi, Byung Soo Kim, Yong Park. Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies. Leukemia Research 2017;57:1
- Tae Yang Song, Sang Hoon Lee, Gun Kim, Hee Jo Baek, Tai Ju Hwang, Hoon Kook. Improvement of treatment outcome over 2 decades in children with acute myeloid leukemia. Blood Res 2018;53:25
- Junshik Hong, Jae Hoon Lee. Recent advances in multiple myeloma: a Korean perspective. Korean J Intern Med 2016;31:820
- Yunsuk Choi, Eun-Hye Hur, Ju Hyun Moon, Bon-Kwan Goo, Dae Ro Choi, Je-Hwan Lee. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome. Korean J Intern Med 2019;34:390
- Young-Eun Kim, Soo Min Ahn, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim. Incidence of and risk factors for myelodysplastic syndrome in patients with rheumatologic diseases. 2023
- Sonia Jaramillo, Richard F. Schlenk. Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?. Curr Oncol Rep 2021;23
- Jina Yun, Young Sok Ji, Geum Ha Jang, Sung Hee Lim, Se Hyung Kim, Chan Kyu Kim, Sang Byung Bae, Jong Ho Won, Seong Kyu Park. TET2 Mutation and High miR-22 Expression as Biomarkers to Predict Clinical Outcome in Myelodysplastic Syndrome Patients Treated with Hypomethylating Therapy. CIMB 2021;43:917
- Amal Al-Haidose, Mohamed A. Yassin, Muna N. Ahmed, Hasna H. Kunhipurayil, Asrar A. Al-Harbi, Musheer A. Aljaberi, Saddam A. Abbasi, Shahram Kordasti, Atiyeh M. Abdallah. Distinct Clinical and Prognostic Features of Myelodysplastic Syndrome in Patients from the Middle East, North Africa, and Beyond: A Systemic Review. JCM 2023;12:2832
- Amina Ismaeel, Eman Farid, Kameela S. Majed, Eman Jasim Mansoor, Jalal Toorani, Faisal Tufail, Romysaa Abdulla Aldanasoury, Sara Ali Alsuwaidi, Durjoy Kumar Shome. Hematologic malignancies of primary bone marrow involvement: a decade's experience in Bahrain. Hematology, Transfusion and Cell Therapy 2023;45:S68
- Yoo-Rin Cho, Yang-Sook Yoo. Factors influencing supportive care needs of multiple myeloma patients treated with chemotherapy. Support Care Cancer 2020;28:1783
- Mehrdad Izadirad, Zoufang Huang, Farideh Jafari, Amir Ali Hamidieh, Ahmad Gharehbaghian, Yi-Dong Li, Leila Jafari, Zhe-Sheng Chen. Extracellular Vesicles in Acute Leukemia: A Mesmerizing Journey With a Focus on Transferred microRNAs. Front. Cell Dev. Biol. 2021;9
- Mihee Kim, Seo-Yeon Ahn, TaeHyung Kim, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Mi Yeon Kim, Ju Heon Park, Myung-Geun Shin, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim. Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine. Hematology 2024;29